Principal Street Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Principal Street Partners's PFE Position: Q4 2023 in Review
Principal Street Partners sold out of Pfizer (PFE) in Q4 2023, closing a stake of 133,806 shares — an estimated $4.44M sold.
Principal Street Partners first reported a position in PFE in Q1 2019 and held it in 19 quarters. The position peaked at $11.6M in Q1 2021. 2,935 funds tracked by Wall St. Rank hold PFE as of Q4 2023.
- Principal Street Partners reported no remaining Pfizer position as of Q4 2023 after selling out during the quarter.
- Principal Street Partners sold 133,806 Pfizer shares in Q4 2023, an estimated $4.44M.
- Principal Street Partners first reported a position in Pfizer in Q1 2019 and held it in 19 quarters.
- Principal Street Partners's Pfizer position peaked at $11.6M in Q1 2021.
- 2,935 funds tracked by Wall St. Rank held Pfizer as of Q4 2023.
Based on Principal Street Partners's 13F filing for Q4 2023, filed 7 Feb 2024.